The Bristol-Myers Squibb Co. has agreed to license its AIDS drug Reyataz free of charge to two Third World generic drug manufacturers.
The move is believed one of the first such agreements involving a second-line AIDS treatment, The Wall Street Journal reported.
The New York-based company announced the agreement Wednesday involving South Africa's Aspen PharmaCare Holdings Ltd. and India's Emcure Pharmaceuticals Ltd. The pharmaceutical companies will be able to manufacture a generic form of Reyataz and sell it in sub-Saharan Africa.
The World Health Organization says more than 1 million people in the Third World are receiving first-line AIDS medicines, but patients usually develop resistance to the drugs within a year and need second-line treatments to fight the virus.
Second-line regimens are up to 30 times as expensive as first-line medications, the relief organization Doctors Without Borders told The Journal.
Reyataz has been found to be especially effective when used in conjunction with another drug made by Abbott Laboratories Inc.
Bristol-Myers began marketing Reyataz in the United States in 2003. The company's patent expires in 2017.
Copyright 2006 by United Press International
Related stories:
3 share Nobel prize for work on AIDS and cancer
(AP) -- Three European scientists shared the 2008 Nobel Prize in medicine on Monday for separate discoveries of viruses that cause AIDS and cervical cancer, breakthroughs that helped doctors fight the deadly diseases.
New findings indicate HIV/AIDS pandemic began around 1900, earlier than previously thought
New research indicates that the most pervasive global strain of HIV began spreading among humans between 1884 and 1924, suggesting that growing urbanization in colonial Africa set the stage for the HIV/AIDS pandemic.
New way to make malaria medicine also first step in finding new antibiotics
University of Illinois microbiology professor William Metcalf and his collaborators have developed a way to mass-produce an antimalarial compound, potentially making the treatment of malaria less expensive.
Operations research promises continued gains for HIV treatment in resource-limited countries
In the past 10 years, the global campaign to expand treatment for millions of people with AIDS living in resource-limited countries, especially in sub-Saharan Africa, has gained substantial commitments in public and private financing, and has made major strides in making treatment available to those who need it. A new collaborative study by researchers at Weill Cornell Medical College and the Clinton Foundation HIV/AIDS Initiative explores how to combine engineering science with medical care to guarantee the long-term success of these treatment programs.
New study finds HIV drug can persist in mothers' milk, increasing risk to them and their babies
A drug commonly used in the developing world to prevent transmission of HIV from mother to child persists in the breast milk and blood of the mothers, putting them and their babies at risk for developing drug-resistant strains of the virus, according to researchers at the Stanford University School of Medicine.
Researchers: Program discourages HIV transmission in Russia
(Boston)-Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) found that sexual behavior counseling during drug addiction treatment should be considered an important component among Russian substance-dependent individuals, in order to decrease risky sexual behavior in the HIV at-risk population. This study appears in the journal
Addiction.
HIV treatment in Africa as successful as in Europe, if started in time
The public health approach to HIV treatment, in which a limited number of drug combinations is used for all patients in South African programs, works just as well as the highly individualized approach to drug selection used in Switzerland, according to research published in
PLoS Medicine.
Disease-detecting lab in the palm of your hand
Detecting food-borne diseases such as campylobacter and salmonella long before they enter the food chain would help ensure that the dinner on your table is safe to eat.